Back to News
Market Impact: 0.15

Private equity’s expanding exit playbook: why a slowdown in IPOs shouldn’t worry you

AAPLMETA
Private Markets & VentureM&A & RestructuringIPOs & SPACsFintechInvestor Sentiment & PositioningTrade Policy & Supply ChainCredit & Bond Markets

Private equity is increasingly decoupling from public markets as IPOs account for only roughly 10–20% of exits by value and HarbourVest Global Private Equity reported that 90% of its recent exits were via M&A rather than listings. Continuation vehicles and secondaries have expanded since 2022 — exemplified by a Froneri continuation involving a €3.6 billion capital injection — while private credit and secondary funds provide alternative liquidity, supporting a fivefold growth in PE-backed companies over 15 years. Listed private equity vehicles such as HVPE broaden retail access to pre-IPO opportunities, and managers are positioned to unlock a backlog of matured assets as institutional allocations to the asset class rise.

Analysis

Market structure is shifting toward concentrated liquidity providers: large alternative managers (e.g., BX, KKR, ARES) and specialist secondaries/private credit firms (OAK, specialist GP-led teams) gain recurring fee pools and pricing power as IPO channels shrink; sell-side IPO-dependent boutiques, small-cap public markets and SPAC sponsors are the obvious losers. Reduced public exit flow tightens the public–private valuation gap, supporting higher buyout multiples and larger continuation capital needs; expect M&A multiples to stay 10–30% above comparable public comps over the next 12–24 months unless rates reprice. Cross-asset impact: upward pressure on leveraged loan and CLO issuance (supporting BKLN-like instruments) and downward pressure on IPO-volume-sensitive equities; corporate credit spreads may compress 20–50bps if private credit scales further, while equity volatility in small-cap/IPO baskets should stay elevated. Tail risks center on a liquidity shock in the secondary market and policy changes (carried-interest taxation, limits on GP-leds) that could force widescale markdowns; a 200–400bps rapid rate spike or a CLO funding freeze would be acute catalysts for NAV repricing. Immediate (days) risk is sentiment swings around any major IPO returning; short term (3–6 months) is M&A cadence and continuation vehicle closings; long term (12–36 months) is institutional allocation flows and possible regulatory action. Hidden dependencies include bank warehouse capacity for LBOs, CLO market health, and mark-to-market policy shifts at large LPs that could force sales. Trade implications: tilt portfolios toward public alternative-asset managers and private-credit exposure while shorting IPO/SPAC/ small-cap IPO proxies. Use directional equity positions (BX, KKR, ARES) sized 1–3% each with 6–12 month horizons, add 2–3% in OAK for private-credit carry, and short the Renaissance IPO ETF (IPO) 1–2% or buy 6–9 month puts to hedge. Options: buy 12-month call spreads on BX/KKR to limit cost; buy 6-month puts on IPO to protect against a sudden return to IPO doldrums. Entry: scale in over 4–12 weeks; exit or re-assess if IPO volume rebounds >50% QoQ or if Fed signals sustained tightening. Contrarian risks: consensus underestimates stop-loss dynamics from LPs forced to mark down private NAVs if credit conditions deteriorate; continuation vehicles mask ultimate exposure and can create headline blow-ups when anchor LPs fail to roll. The market may be underpricing the political/regulatory tail — a modest carried-interest change could erase multi-quarter fee growth expectations and trigger 20–40% multiple compression for managers. Historical parallel: post-2006 private-credit leverage expansion that reversed in 2008; this time dry powder is larger but funding markets are thinner, so rapid de-risk scenarios are possible and should be stress-tested in position sizing.